Bedfont® Scientific Ltd. acquires US-based company coVitaTM , marking the next chapter in its global growth
Bedfont®, a world leader in breath analysis, announces its acquisition of coVitaTM, building on 16 years of partnership, market knowledge, and established infrastructure to support global expansion.
Read original article on The Medical News →Related news
-
Triple-action drug retatrutide delivers major weight loss for people with diabetes, Phase III trial finds
United Kingdom
-
Technology-assisted approach can help prevent summer weight gain in adolescents
United Kingdom
-
Why managing vibration is critical in IVF
United Kingdom
-
Neck stiffness puts pitchers at risk of throwing-related injuries
United Kingdom
-
AI tool reveals what attracts immune cells to tumors and what keeps them away
United Kingdom
-
New research shows reduced toxicant exposure reduces biological activity
United Kingdom
-
AI screening helps more people with diabetes access sight-saving eye care
United Kingdom
-
Exposure to 'safer' plastic additive during pregnancy linked to smaller birth size
United Kingdom